Iscalimab, an investigational antibody therapy from Novartis, showed promise for safety and preliminary efficacy for lessening disease activity…
Articles by Ana Pena, PhD
Many people with Sjögren’s syndrome experience oral symptoms beyond mouth dryness — with trouble in speaking, oral ulcers, and…
Orencia (abatacept), an immunotherapy used in rheumatic diseases, failed to reduce disease activity in patients with early active…
Interstitial lung disease (ILD), or lung tissue scarring, commonly occurs in people with primary Sjögren’s syndrome in China…
Immunoglobulin injections may be a good choice to help resolve damage to the nerves that…
New diagnostic criteria for systemic lupus erythematosus (SLE), released by the European and American rheumatology societies, helps to better…
Immune regulatory B-cells (Bregs) are less abundant in patients with primary Sjögren’s syndrome, and are inversely correlated with disease…
Eye drops that contain a DNA-degrading enzyme are safe and potentially effective against eye damage and discomfort in…
A supervised walking program, practiced three times a week for 16 weeks, safely improves cardiorespiratory fitness and exercise…
Women with primary Sjögren’s syndrome (pSS) do not need to follow specific dietary guidelines to  maintain good…